Koppert and Amoeba a proactive synergy to develop biofingicides

Koppert, the global leader in biological crop protection and pollination, and Amoéba, specialized in natural microbiological solutions based on the patented use of amoebae, announced a significant commercial agreement which focuses on the innovative biofungicide solutions expected to be launched early 2026.

A multi-crop, multi-country agreement

The innovative biofungicide solution is based on the lysate of the amoeba Willaertia magna C2c Maky. It is an environmentally friendly biofungicide, that protects crops against a broad range of diseases. The agreement grants Koppert exclusive distribution rights for a period of five years for this biocontrol product, targeting vines and vegetable crops grown both in greenhouses and open fields across 18 European countries[1] (including France, the Netherlands, Germany, Italy), as well as in the United States. The launch is expected in early 2026, and Koppert will distribute this biofungicide under its own brand name. In addition, Koppert and Amoéba will collaborate for the potential launch in Brazil. Koppert

New opportunities ahead for both companies

The two companies will also begin discussions on the co-development of new biofungicide solutions for the crops covered by this agreement. By combining their respective product ranges and complementary expertise, they aim to deliver more effective and sustainable biological solutions that address growers’ needs and support healthier crops. These solutions will also have strong market potential and significant growth opportunities in the coming years. This strategic milestone reinforces Koppert’s leadership in the biocontrol industry and highlights both companies’ shared commitment to advancing sustainable agriculture. For more information about Koppert and Amoeba, you can write here.